Walgreens Boots Alliance Inc (WBA) was Resumed by BofA/Merrill to “Buy”. BofA/Merrill advised their investors in a research report released on Jun 7, 2016.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by Barclays on Mar 10, 2016 to “Equal Weight” and Lowered the Price Target to $ 76 from a previous price target of $81 .
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 5, 2016. Analyst had a consensus of $1.28. The company had revenue of $30184.00 million for the quarter, compared to analysts expectations of $30666.29 million. The company’s revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS.
Walgreens Boots Alliance Inc closed down -0.42 points or -0.53% at $78.68 with 24,88,399 shares getting traded on Friday. Post opening the session at $79.14, the shares hit an intraday low of $78.16 and an intraday high of $79.14 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Apr 25, 2016, William C Foote (director) sold 2,066 shares at $80.99 per share price. According to the SEC, on Apr 18, 2016, George Rollo Fairweather (EVP and Global CFO) sold 50,000 shares at $81.52 per share price. On Mar 11, 2016, Kathleen Wilson-thompson (EVP and Global Chief HRO) sold 15,873 shares at $83.03 per share price, according to the Form-4 filing with the securities and exchange commission.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.